KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Tax Provisions (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Tax Provisions for 16 consecutive years, with $150.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Tax Provisions rose 12.78% year-over-year to $150.0 million, compared with a TTM value of $658.0 million through Dec 2024, up 131.69%, and an annual FY2025 reading of $547.0 million, down 16.74% over the prior year.
  • Tax Provisions was $150.0 million for Q4 2024 at Thermo Fisher Scientific, up from $99.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $416.0 million in Q2 2021 and bottomed at $31.0 million in Q4 2022.
  • Average Tax Provisions over 5 years is $180.2 million, with a median of $161.5 million recorded in 2022.
  • The sharpest move saw Tax Provisions surged 1900.0% in 2020, then crashed 88.56% in 2022.
  • Year by year, Tax Provisions stood at $394.0 million in 2020, then crashed by 48.48% to $203.0 million in 2021, then dropped by 14.78% to $173.0 million in 2022, then fell by 23.12% to $133.0 million in 2023, then increased by 12.78% to $150.0 million in 2024.
  • Business Quant data shows Tax Provisions for TMO at $150.0 million in Q4 2024, $99.0 million in Q3 2024, and $128.0 million in Q2 2024.